By Business/Source
Currency:USD
2022/FY
Stock NameRevenueRatio
Discovery and development of novel oncology therapeutics3.11M100.00%
By Country/Region
Currency:USD
2022/FY
Stock NameRevenueRatio
United States3.11M100.00%